This inventor holds 1 USPTO granted patent. Top assignee: Transform Pharmaceuticals, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovations of Stephen Soukasene in Pharmaceutical Chemistry
Introduction
Stephen Soukasene is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel forms of Ritonavir. His work has implications for the treatment of diseases such as HIV-infection.
Latest Patents
Stephen Soukasene holds 1 patent for his invention titled "Solvates and polymorphs of ritonavir and methods of making and using the same." This patent discloses novel solvates and crystal polymorphs of Ritonavir, along with methods for their production. Specific solvates include a formamide solvate and a partially desolvated solvate. The patent also outlines methods for creating previously known forms of Ritonavir and discusses the use of these novel forms in pharmaceutical compositions and unit dosage forms.
Career Highlights
Stephen is associated with Transform Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His research focuses on enhancing the efficacy and usability of Ritonavir, contributing to advancements in HIV treatment.
Collaborations
Stephen has collaborated with notable colleagues, including Sherry Morissette and Orn Almarsson, to further his research and development efforts in the pharmaceutical field.
Conclusion
Stephen Soukasene's work exemplifies the intersection of innovation and healthcare, showcasing how novel inventions can lead to improved treatment options for serious diseases. His contributions to the field of pharmaceutical chemistry are invaluable and continue to impact the industry positively.